Self-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin
- PMID: 26998252
- PMCID: PMC4792303
- DOI: 10.1039/C5RA25044G
Self-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin
Abstract
Rifampicin (RIF) is a benchmark drug for treatment of tuberculosis, but poor bioavailability, prolonged treatment, and pill burden have been linked to therapeutic failure and the development of multidrug resistant strains. To overcome these limitations, this study investigated a method of rifampicin nanoencapsulation and aerosol delivery using a commercial, hand-held nebulizer modified with a nitrogen stream.
Figures
) or 5 L/min (
). Inserts: Micrograph of NP analyzed by high resolution scanning electron microscope (STEM) FE Hitachi S-5500 (0.4 nm at 5kV) with a BF/DF Duo-STEM detector.
References
-
- Moretton MA, Glisoni RJ, Chiappetta DA, Sosnik A. Colloids Surf B. 2010;79:467–479. - PubMed
-
- WHO. Global Tuberculosis report 2014. 2015 Agust; http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?....
-
- Burman WJ, Gallicano K, Peloquin C. Clin Pharmacokinet. 2001;40:327–341. - PubMed
-
- Gürsoy A, Kut E, Özkırımlı S. Int J Pharm. 2004;271:115–123. - PubMed
-
- Parmar R, Misra R, Mohanty S. Colloids Surf B Biointerfaces. 2015;129:198–205. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources